Charities urge action on rare diseases from European Parliament

May 31, 2024

Elections to the European Parliament are scheduled for next week (June 6 – 9). Although the UK is no longer a member state, our charity continues to collaborate closely with counterparts in EU member states on issues affecting people with liver disease. We are committed to combating all forms of childhood liver diseases, and it is crucial to unite with others across Europe to address these rare conditions. While most liver diseases affecting adults are preventable, around 10% are also classified as rare diseases.

Our Chief Executive, Pamela Healy, is a signatory of an open letter to the European Commission, urging the next European leaders to:

  • Prioritise health in future policies and programs
  • Develop a comprehensive European Action Plan for rare diseases that bridges diverse policy areas and aligns existing efforts with clear, measurable objectives
  • Immediately address the urgent needs of the rare disease population by implementing actions identified by EURODIS (Rare Disease Europe)

Click here to read the open letter.

More news

A new chapter for liver health: together we are Liver UK

A new chapter for liver health: together we are Liver UK

Today, we take the next step in that journey as Liver UK: a stronger, clearer and more united voice for liver health.
Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

The British Liver Trust welcomes the news that hundreds more liver transplants could be carried out after a new procedure that supplies a donor liver with oxygen before removal was approved by NICE for use in the NHS.   In-situ ...
New hope for people living with MASH as two treatments receive MHRA approval

New hope for people living with MASH as two treatments receive MHRA approval

People living with metabolic dysfunction-associated steatohepatitis (MASH) have received encouraging news, with the UK medicines regulator approving two treatments for the condition within the past month. The Medicines and Healthcare ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.